المؤلفون: Reis-Neto ETD; Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/Unifesp), Otonis Street, 863, 2 Floor, Vila Clementino, São Paulo, SP, 04025-002, Brazil. edgard.torres@unifesp.br., Seguro LPC; Division of Rheumatology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Sato EI; Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/Unifesp), Otonis Street, 863, 2 Floor, Vila Clementino, São Paulo, SP, 04025-002, Brazil., Borba EF; Division of Rheumatology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Klumb EM; Department of Rheumatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Costallat LTL; Division of Rheumatology, Department of Orthopedics, Rheumatology and Traumatology, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil., Medeiros MMDC; Division of Rheumatology, Universidade Federal do Ceará (UFC), Fortaleza, Brazil., Bonfá E; Division of Rheumatology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Araújo NC; Division of Rheumatology, Hospital do Servidor Público Estadual de São Paulo - Instituto de Assistência Médica ao Servidor Público Estadual de São Paulo, São Paulo, Brazil., Appenzeller S; Division of Rheumatology, Department of Orthopedics, Rheumatology and Traumatology, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil., Montandon ACOES; Division of Rheumatology, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Brazil., Yuki EFN; Division of Rheumatology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Teixeira RCA; Division of Rheumatology, Universidade Estadual de Ciências da Saúde de Alagoas, Maceió, Brazil., Telles RW; Division of Rheumatology, Faculdade de Medicina da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil., Egypto DCSD; Division of Rheumatology, Department of Internal Medicine, Universidade Federal da Paraíba (UFPB), João Pessoa, Brazil., Ribeiro FM; Department of Rheumatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Gasparin AA; Division of Rheumatology, Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil., Junior ASA; Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/Unifesp), Otonis Street, 863, 2 Floor, Vila Clementino, São Paulo, SP, 04025-002, Brazil., Neiva CLS; Division of Rheumatology, Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil., Calderaro DC; Division of Rheumatology, Faculdade de Medicina da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil., Monticielo OA; Division of Rheumatology, Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.

المصدر: Advances in rheumatology (London, England) [Adv Rheumatol] 2024 Jun 18; Vol. 64 (1), pp. 48. Date of Electronic Publication: 2024 Jun 18.

نوع المنشور: Journal Article; Practice Guideline; Consensus Development Conference; Systematic Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101734172 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3106 (Electronic) Linking ISSN: 25233106 NLM ISO Abbreviation: Adv Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Nephritis*/diagnosis , Lupus Nephritis*/drug therapy , Immunosuppressive Agents*/therapeutic use , Societies, Medical*, Humans ; Brazil ; Creatinine/blood ; Proteinuria/diagnosis ; Proteinuria/etiology ; Mycophenolic Acid/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Rheumatology/standards ; Rituximab/therapeutic use ; Biopsy ; Cyclophosphamide/therapeutic use ; Leflunomide/therapeutic use ; Glucocorticoids/therapeutic use ; Hydroxychloroquine/therapeutic use ; Azathioprine/therapeutic use ; Remission Induction ; Cyclosporine/therapeutic use ; Evidence-Based Medicine ; Consensus ; Disease Progression ; Kidney Failure, Chronic ; Randomized Controlled Trials as Topic

المؤلفون: Teixeira RCA; From the *Department of Internal Medicine, Universidade Estadual de Ciências da Saúde de Alagoas (UNCISAL), Maceió Alagoas; †Department of Internal Medicine, Universidade de São Paulo (USP); ‡Department of Internal Medicine, Hospital Santa Casa de Maceió, Maceió Alagoas; and §Department of Internal Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil., Borba Neto EF, Christopoulos GB, Sato EI

المصدر: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2017 Aug; Vol. 23 (5), pp. 246-251.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9518034 Publication Model: Print Cited Medium: Internet ISSN: 1536-7355 (Electronic) Linking ISSN: 10761608 NLM ISO Abbreviation: J Clin Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Erythematosus, Systemic*/diagnosis , Lupus Erythematosus, Systemic*/epidemiology , Lupus Erythematosus, Systemic*/therapy , Social Class*, Adult ; Brazil/epidemiology ; Female ; Humans ; Male ; Needs Assessment ; Patient Acuity ; Quality Improvement ; Risk Factors ; Severity of Illness Index